Active Ingredient(s):Levomilnacipran FDA Approved: * July 25, 2013 Pharm Company: *FOREST LABS INC Category:Antidepressant
Levomilnacipran (brand name Fetzima) is an antidepressant which was approved in the United States in 2013 for the treatment of major depressive disorder (MDD) in adults. It is the levorotatory enantiomer of milnacipran, and has similar effects and pharmacology, acting as a serotonin–norepinephrine reuptake inhibitor (SNRI).
1 Medical uses
2 Side effects
* May have multiple approval dates, manufacturers, or labelers. 3 Discussions